Search Results
Results found for "career development"
- Finance is Science too: How Numbers Keep the Lights On with Chuck DeWeese & Joe St. Germain | Dr. GPCR Ecosystem
Chuck DeWeese, controller at CLP, joined the mission after pivoting from a sales career into accounting
- You never know where your GPCR takes you with Dr. Brian Hudson | Dr. GPCR Ecosystem
He has more than 20 years of experience in GPCR, primarily focused on drug discovery and developing new
- Robert Laprairie | Dr. GPCR Ecosystem
Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and Development
- Tanishka S. Saraf | Dr. GPCR Ecosystem
nervous system disorders realm to understand the neurobiology of neuropsychiatric disorders and to develop
- Dr. Nicolas Gilles | Dr. GPCR Ecosystem
properties of these new ligands are deemed exceptional, a lead optimization is realized and its therapeutic development
- FAQ | Dr. GPCR Ecosystem
Will attending help with continuing education or professional development? Yes. These webinars are designed to support ongoing scientific development in GPCR pharmacology and drug discovery
- Empowering Drug Discovery for the GPCR Community with Dr. Justin English | Dr. GPCR Ecosystem
His lab focuses on developing and innovating technologies to solve broad questions in pharmacology, with
- Why Mosquitoes Hunt You: GPCR Control of Blood Feeding and Mating | Dr. GPCR Ecosystem
Listeners interested in GPCR drug discovery, functional assay development, or fluorescence-based assays Why the study of conserved receptor pathways enables the development of broadly effective, species-independent
- Dr. Josh Pottel | Dr. GPCR Ecosystem
(MFI): a reliable, self-sustaining computational chemistry service provider, developing its own software
- Dr. Neil Grimsey | Dr. GPCR Ecosystem
We have developed an array of fluorescent biosensors to map kinase activity in living cells and are exploring
- GPCR location matters with Dr. Gabriele Kockelkoren | Dr. GPCR Ecosystem
Alice Ting developing programmable receptors for molecular sensing and controlling cellular behaviour
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
She developed expertise over the past two decades studying structure/function relationships of GPCRs
- Dr. Juan José Fung | Dr. GPCR Ecosystem
His current work is mainly focused on screening and assay development to bridge the gap between in vitro
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
Kenakin , a leading expert in pharmacology, as he unpacks the fascinating world of signaling bias in drug development effects. 🗣️ Interactive Q&A : The discussion wraps up with an insightful Q&A, tackling real-world drug development Understanding these shifts can revolutionize drug development! The talk explores how to navigate this crucial gap. 📌 The Future of Drug Development 🚀 🔹 By integrating
- Vaithish Velazhahan | Dr. GPCR Ecosystem
He has developed novel tools and methodologies to study fungal GPCRs which allowed the determination
- The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem
She is an internationally recognized biophysicist for her contributions in developing constrained molecular
- Terry Hébert | Dr. GPCR Ecosystem
His work is grounded in careful assay development and a conviction that the signaling space around a Vaccine development at scale — How to read a landscape of 90+ parallel vaccine candidates without confusing BRET-based platform for capturing downstream signaling, built with the Bouvier lab — illustrates how assay-development
- Sri Kosuri | Dr. GPCR Ecosystem
He is passionate about developing more rational ways to understand and engineer biology.
- Dr. Adriano Marchese | Dr. GPCR Ecosystem
The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic development
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
deciphering of cellular and organ functions, which require individual adhesion GPCRs, and extends to the development
- Dr. Robert F. Bruns | Dr. GPCR Ecosystem
During a joint postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
I am continuing with the development of advanced screening approaches in the Madan Babu lab to progress
- Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem
Wisconsin-Madison and later in the Ploegh lab at Harvard Medical School and Boston Children's Hospital, he developed completed his postdoctoral training at MIT and Harvard Med School in the lab of Hidde Ploegh , where he developed Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
Episode Timeline 00:00 Introduction 02:09 From Buenos Aires to NIH: a career that followed the science
- InĂŞs Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche | Dr. GPCR Ecosystem
She developed expertise over the past two decades studying structure/function relationships of GPCRs
- Dr. Sudarshan Rajagopal | Dr. GPCR Ecosystem
Lefkowitz , where his research focused on biased agonism, with the development of approaches to quantify
- Dr GPCR Ecosystem Feedback | Dr. GPCR Ecosystem
Develop new tools, training programs, and mentorship programs tailored to your specific needs.
- Dr. Davide Calebiro | Dr. GPCR Ecosystem
To study GPCR signalling, they develop and use innovative optical methods based on FRET and single-molecule
- Dr. Bianca Plouffe | Dr. GPCR Ecosystem
In 2018, Bianca was appointed Vice-Chancellor’s Fellow at Queen’s University Belfast to develop her research
- Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem
Case Western to leading a thirty-person GPCR lab at UNC is worth sitting with — particularly for early-career




























